These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 26481343)

  • 1. The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis.
    Okamoto T; Fujii M; Furusawa H; Tsuchiya K; Miyazaki Y; Inase N
    Respir Med; 2015 Dec; 109(12):1576-81. PubMed ID: 26481343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
    Xue M; Guo Z; Cai C; Sun B; Wang H
    Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant protein-D is more useful than Krebs von den Lungen 6 as a marker for the early diagnosis of interstitial pneumonitis during pegylated interferon treatment for chronic hepatitis C.
    Ishikawa T; Kubota T; Abe H; Hirose K; Nagashima A; Togashi T; Seki K; Honma T; Yoshida T; Kamimura T
    Hepatogastroenterology; 2012 Oct; 59(119):2260-3. PubMed ID: 23435141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of serum surfactant protein-D as a prognostic predictor in fibrotic hypersensitivity pneumonitis.
    Ejima M; Okamoto T; Suzuki T; Miyazaki Y
    Respir Investig; 2022 May; 60(3):369-378. PubMed ID: 34998715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.
    Hamai K; Iwamoto H; Ishikawa N; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N; Kohno N
    Dis Markers; 2016; 2016():4759040. PubMed ID: 27293304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia.
    Yamakawa H; Hagiwara E; Ikeda S; Iwasawa T; Otoshi R; Tabata E; Okuda R; Sekine A; Baba T; Iso S; Okudela K; Takemura T; Ogura T
    Respir Investig; 2019 Sep; 57(5):422-429. PubMed ID: 31003951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity pneumonitis caused by Penicillium citrinum, not Enoki spores.
    Yoshikawa S; Tsushima K; Yasuo M; Fujimoto K; Kubo K; Kumagai T; Yamazaki Y
    Am J Ind Med; 2007 Dec; 50(12):1010-7. PubMed ID: 17979128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis.
    Yoshikawa T; Otsuka M; Chiba H; Ikeda K; Mori Y; Umeda Y; Nishikiori H; Kuronuma K; Takahashi H
    BMC Pulm Med; 2020 Jan; 20(1):27. PubMed ID: 32005219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YKL-40 and KL-6 Levels in Serum and Sputum of Patients Diagnosed With Hypersensitivity Pneumonitis.
    Sánchez-Díez S; Munoz X; Ojanguren I; Romero-Mesones C; Espejo D; Villar A; Gómez-Olles S; Cruz MJ
    J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2414-2423. PubMed ID: 35788062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen avoidance tests for diagnosis of chronic hypersensitivity pneumonitis.
    Tsutsui T; Miyazaki Y; Okamoto T; Tateishi T; Furusawa H; Tsuchiya K; Fujie T; Tamaoka M; Sakashita H; Sumi Y; Inase N
    Respir Investig; 2015 Sep; 53(5):217-24. PubMed ID: 26344611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects for hypersensitivity pneumonitis induced by Japanese mushroom (Bunashimeji).
    Tsushima K; Furuya S; Yoshikawa S; Yasuo M; Yamazaki Y; Koizumi T; Fujimoto K; Kubo K
    Am J Ind Med; 2006 Oct; 49(10):826-35. PubMed ID: 16948148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum heat shock protein 47 levels in patients with drug-induced lung disease.
    Kakugawa T; Yokota S; Ishimatsu Y; Hayashi T; Nakashima S; Hara S; Sakamoto N; Matsuoka Y; Kubota H; Mine M; Mukae H; Nagata K; Kohno S
    Respir Res; 2013 Nov; 14(1):133. PubMed ID: 24256690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases].
    Zhu C; Zhao YB; Kong LF; Li ZH; Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):93-7. PubMed ID: 26879611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis.
    Lin FC; Chen YC; Chang SC
    Mayo Clin Proc; 2008 Dec; 83(12):1344-9. PubMed ID: 19046553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of serum anti-granulocyte-macrophage colony-stimulating factor autoantibodies in patients with sarcoidosis and hypersensitivity pneumonitis.
    Katayama K; Hirose M; Arai T; Hatsuda K; Tachibana K; Sugawara R; Sugimoto C; Kasai T; Akira M; Inoue Y
    Orphanet J Rare Dis; 2020 Sep; 15(1):272. PubMed ID: 32993757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum heat shock protein 47 levels are elevated in acute exacerbation of idiopathic pulmonary fibrosis.
    Kakugawa T; Yokota S; Ishimatsu Y; Hayashi T; Nakashima S; Hara S; Sakamoto N; Kubota H; Mine M; Matsuoka Y; Mukae H; Nagata K; Kohno S
    Cell Stress Chaperones; 2013 Sep; 18(5):581-90. PubMed ID: 23435730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Outcome of patients with acute exacerbation of idiopathic interstitial fibrosis (IPF) treated with sivelestat and the prognostic value of serum KL-6 and surfactant protein D].
    Nakamura M; Ogura T; Miyazawa N; Tagawa A; Kozawa S; Watanuki Y; Takahashi H
    Nihon Kokyuki Gakkai Zasshi; 2007 Jun; 45(6):455-9. PubMed ID: 17644940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic summer-type hypersensitivity pneumonitis: clinical similarities to idiopathic pulmonary fibrosis.
    Inase N; Ohtani Y; Usui Y; Miyazaki Y; Takemura T; Yoshizawa Y
    Sarcoidosis Vasc Diffuse Lung Dis; 2007 Sep; 24(2):141-7. PubMed ID: 18496985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the study of biomarkers of idiopathic pulmonary fibrosis in Japan.
    Huang H; Peng X; Nakajima J
    Biosci Trends; 2013 Aug; 7(4):172-7. PubMed ID: 24056167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.